Deal Tracker · Therapeutic areas

Oncology deals

19 Oncology deals tracked by EPT across MENA, GCC & Africa — licensing, distribution & partnerships. Most active: ADCAN Pharma, Bio-Thera Solutions, Hikma Pharmaceuticals & Mubadala Bio. Latest: Miltenyi Biomedicine → Abu Dhabi Stem Cells Center (Partnership / Collaboration, 22 Oct 2026).

• Miltenyi Biomedicine → Abu Dhabi Stem Cells Center
  Partnership / Collaboration · GCC · 22 Oct 2026
• Mubadala Bio → Modern Pharmaceutical
  Distribution · GCC · 21 Oct 2026
• Lotus Pharmaceutical → ADCAN Pharma
  Licensing · MENA · 9 Oct 2026
• Dhofar Pharmaceutical Industries → Hydrogen Oncology Pharmaceuticals
  Technology transfer / Localization · MENA · 8 Oct 2026
• Elpen → ADCAN Pharma
  Licensing · GCC · 7 Oct 2026
• Cordex Biologics → Farma Mondo
  Distribution · GCC · 25 Sept 2026
• Shilpa Biologicals → SPIMACO
  Licensing · MENA · Undisclosed · 15 Sept 2026
• Roche → Groupe Saidal
  Technology transfer / Localization · Africa · Undisclosed · 10 Sept 2026
• Pharmacare Premium → Arabian Oasis
  Partnership / Collaboration · GCC · Undisclosed · 3 Sept 2026
• Pinnacle Life Science → ADCAN Pharma
  Licensing · GCC · Undisclosed · 2 Sept 2026
• Northwest Biotherapeutics → SPIMACO
  Partnership / Collaboration · MENA · Undisclosed · 12 Jul 2026
• Biosidus → Mubadala Bio
  Licensing · GCC · Undisclosed · 24 Jun 2026
• CEL-SCI → Saudi Amarox
  Distribution · MENA · Undisclosed · 22 Jun 2026
• Bio-Thera Solutions → Avalon Pharma
  Licensing · MENA · Undisclosed · 3 Feb 2026
• ONConcept® Consortium — Bluepharma · Helm · Welding → Dar Al Dawa
  Distribution · MENA · Undisclosed · 11 May 2025
• Shanghai Henlius Biotech → SaudiVax
  Joint venture · MENA · Undisclosed · 8 Nov 2024
• Immuneel Therapeutics → Taiba Healthcare
  Equity / Investment · MENA · $12m · 30 Jul 2024
• Shanghai Junshi Biosciences → Hikma Pharmaceuticals
  Licensing · MENA · See terms · 26 Dec 2022
• Bio-Thera Solutions → Hikma Pharmaceuticals
  Licensing · Undisclosed · 27 Aug 2021